Logo

Millennium Identifies 18 Drug Targets for Bayer

Oct 08, 1999
Premium

CAMBRIDGE, Mass.--Millennium Pharmaceuticals and Bayer announced that they have identified 18 novel drug targets and moved four of them into high-throughput screening in less than eight months. In the collaboration, which is taking a production-oriented approach based on genomics research to move compounds toward clinical trials, targets were identified and validated by Millennium and are being screened by Bayer.

Filed under

Informatics
Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.